Investments
15Portfolio Exits
8
Want to inform investors similar to Dorset Management Corporation about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Dorset Management Corporation News
Aug 15, 2015
SHARES: 800 shares of common stock at $96.4543 per share; 9,875 shares of common stock at $96.4543 per share; 2,600 shares of common stock at $96.4543 per share; 2,000 shares of common stock at $96.1957 per share; 27,300 shares of common stock at $96.1957 per share; and 7,225 shares of common stock at $96.1957 per share NOW HOLDS: 1,843 1. NATURE OF INDIRECT BENEFICIAL OWNERSHIP: The Reporting Person is the managing member of Knott Partners Management, LLC , which is (a) the sole general partner of Shoshone Partners, L.P. Knott Partners Offshore Master Fund, L.P. and (b) the managing general partner of Knott Partners, L.P. The Reporting Person is also a general partner of Knott Partners, L.P. 2. NATURE OF INDIRECT BENEFICIAL OWNERSHIP: The Reporting Person is the sole director and the president of Dorset Management Corporation , which provides investment management services to separate institutional managed accounts (each, a "Managed Account"), and (b) the spouse of the immediate family member (the "Spouse"). 3. NATURE OF INDIRECT BENEFICIAL OWNERSHIP: As a result of the Reporting Person's interests in Knott Partners Management, LLC and in Dorset Management Corporation , the Reporting Person has investment discretion and control over the securities in this entry. Except with respect to those securities held by the Spouse, the Reporting Person may be deemed indirectly to beneficially own the securities in this entry as a result of a performance related fee. Except with respect to the Reporting Person's beneficial interest in Knott Partners, L.P. Knott Partners Offshore Master Fund, L.P. , and Shoshone Partners, L.P. , the Reporting Person disclaims beneficial ownership of the securities beneficially owned by the Managed Account, except to the extent ultimately realized. Each of Knott Partners, L.P. Knott Partners Offshore Master Fund, L.P. , Shoshone Partners, L.P. , the Managed Account and the Spouse disclaims beneficial ownership of securities reported as owned by any other party. Link: http://www.sec.gov/Archives/edgar/data/808722/000110465915059968/xslF345X03/a4.xml
Dorset Management Corporation Investments
15 Investments
Dorset Management Corporation has made 15 investments. Their latest investment was in Columbia Laboratories as part of their Unattributed VC - IV on December 12, 2006.

Dorset Management Corporation Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
12/11/2006 | Unattributed VC - IV | Columbia Laboratories | $40M | No | ||
6/13/2006 | PIPE - II | IPIX | $5M | No | ||
5/5/2006 | PIPE | Alaunos Therapeutics | $37M | Yes | Abu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, FCP OP MEDICAL BioHelth-Trends, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, Knott Partners, LBi International, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management | |
10/5/2005 | PIPE | |||||
9/20/2005 | PIPE - IV |
Date | 12/11/2006 | 6/13/2006 | 5/5/2006 | 10/5/2005 | 9/20/2005 |
---|---|---|---|---|---|
Round | Unattributed VC - IV | PIPE - II | PIPE | PIPE | PIPE - IV |
Company | Columbia Laboratories | IPIX | Alaunos Therapeutics | ||
Amount | $40M | $5M | $37M | ||
New? | No | No | Yes | ||
Co-Investors | Abu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, FCP OP MEDICAL BioHelth-Trends, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, Knott Partners, LBi International, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management | ||||
Sources |
Dorset Management Corporation Portfolio Exits
8 Portfolio Exits
Dorset Management Corporation has 8 portfolio exits. Their latest portfolio exit was Spectrum Pharmaceuticals on June 24, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/24/2017 | Acq - P2P | 2 | |||
Date | 6/24/2017 | ||||
---|---|---|---|---|---|
Exit | Acq - P2P | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
Dorset Management Corporation Acquisitions
1 Acquisition
Dorset Management Corporation acquired 1 company. Their latest acquisition was Ventyx on January 18, 1999.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
1/18/1999 | Acquired |
Date | 1/18/1999 |
---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.